First National Advisers’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-5,607
| Closed | -$233K | – | 216 |
|
|
2024
Q2 | $233K | Sell |
5,607
-13,205
| -70% | -$548K | 0.04% | 204 |
|
|
2024
Q1 | $1.13M | Buy |
18,812
+7,595
| +68% | +$455K | 0.25% | 118 |
|
|
2023
Q4 | $576K | Sell |
11,217
-7,620
| -40% | -$391K | 0.17% | 130 |
|
|
2023
Q3 | $1.09M | Buy |
18,837
+12,054
| +178% | +$700K | 0.49% | 72 |
|
|
2023
Q2 | $434K | Sell |
6,783
-300
| -4% | -$19.2K | 0.4% | 78 |
|
|
2023
Q1 | $491K | Buy |
7,083
+1,332
| +23% | +$92.3K | 0.56% | 68 |
|
|
2022
Q4 | $414K | Buy |
5,751
+2,549
| +80% | +$183K | 0.53% | 73 |
|
|
2022
Q3 | $228K | Buy |
+3,202
| New | +$228K | 0.34% | 91 |
|